Balaxi Pharmaceuticals Limited’s (BALAXI) Moving Averages Convergence Divergence (MACD) indicator is 0.20, suggesting Balaxi Pharmaceuticals Limited is a Sell.
Balaxi Pharmaceuticals Limited’s (BALAXI) 20-Day exponential moving average is 21.80, while Balaxi Pharmaceuticals Limited’s (BALAXI) share price is ₹23.44, making it a Buy.
Balaxi Pharmaceuticals Limited’s (BALAXI) 50-Day exponential moving average is 22.18, while Balaxi Pharmaceuticals Limited’s (BALAXI) share price is ₹23.44, making it a Buy.
Balaxi Pharmaceuticals Limited’s (BALAXI) 10-Day exponential moving average is 22.18, while Balaxi Pharmaceuticals Limited’s (BALAXI) share price is ₹23.44, making it a Buy.
Balaxi Pharmaceuticals Limited’s (BALAXI) 100-Day exponential moving average is 22.91, while Balaxi Pharmaceuticals Limited’s (BALAXI) share price is ₹23.44, making it a Buy.
Balaxi Pharmaceuticals Limited’s (BALAXI) stock price is ₹23.44 and Balaxi Pharmaceuticals Limited’s (BALAXI) 50-day simple moving average is 22.39, creating a Buy signal.
Balaxi Pharmaceuticals Limited’s (BALAXI) stock price is ₹23.44 and Balaxi Pharmaceuticals Limited’s (BALAXI) 100-day simple moving average is 23.05, creating a Buy signal.
Balaxi Pharmaceuticals Limited’s (BALAXI) stock price is ₹23.44 and Balaxi Pharmaceuticals Limited’s (BALAXI) 200-day simple moving average is 23.08, creating a Buy signal.